AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glidivas M 1mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Redmax Pharma

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glidivas M 1mg/500mg Tablet

Diabetic patients using Glimepiride/Metformin 1mg/500mg tablets should understand that this anti-diabetic medication, a dual-drug formulation, manages type 2 diabetes in adults by regulating blood glucose. Optimal efficacy requires consistent daily ingestion at the same time, ideally with food. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Discontinuing this medication without medical supervision risks dangerously elevated blood sugar, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements, not replaces, a comprehensive diabetes management plan encompassing diet, exercise, and weight control as directed by your doctor. Commonly, low blood sugar (hypoglycemia) manifests as sweating, dizziness, headache, or tremors. Carrying a readily available fast-acting glucose source (e.g., sugary snacks or juice) is crucial. Alcohol consumption increases hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe liver or kidney disease. Individuals with a history of heart disease should discuss its suitability with their physician. Pregnant or breastfeeding women require medical consultation prior to use. Regular blood glucose monitoring is vital, along with periodic blood tests to evaluate blood cell counts and liver function.

Uses of Glidivas M 1mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Glidivas M 1mg/500mg Tablet:

Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glidivas M 1mg/500mg tablets should be administered with a meal.

Common Side effects of Glidivas M 1mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glidivas M 1mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glidivas M 1mg/500mg Tablet whole; avoid chewing, crushing, or breaking it. Administer this medicine with a meal.

How Glidivas M 1mg/500mg Tablet works:

Glidivas M 1mg/500mg tablets contain glimepiride and metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Alcohol consumption alongside Glidivas M 1mg/500mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glidivas M 1mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before taking this medication.

Breast feedingBreast feedingUNSAFE

Breastfeeding mothers should avoid Glidivas M 1mg/500mg tablets. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Impaired driving is possible with both hypo- and hyperglycemia. Refrain from driving if these conditions arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glidivas M 1mg/500mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is essential. Glidivas M 1mg/500mg tablets are contraindicated in patients with severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Exercise caution when administering Glidivas M 1mg/500mg tablets to individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is advised. For patients exhibiting mild to moderate liver dysfunction, initiate treatment with a reduced Glidivas M 1mg/500mg tablet dosage; however, its use is contraindicated in those with severe liver disease.

What if you forget to take Glidivas M 1mg/500mg Tablet :

Should you forget a Glidivas M 1mg/500mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glidivas M 1mg/500mg Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes medication

FAQs on Glidivas M 1mg/500mg Tablet

Store this medication in its original, tightly closed container, following the storage instructions on the label. Dispose of any unused medication properly and keep it out of reach of children, pets, and others.
Glidivas M 1mg/500mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Glidivas M 1mg/500mg Tablets and seek immediate medical attention.
Glidivas M 1mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glidivas M 1mg/500mg Tablets may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged Glidivas M 1mg/500mg Tablet use can lead to Vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental Vitamin B12 is recommended by some researchers.
Glidivas M 1mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glidivas M 1mg/500mg tablets with alcohol is unsafe. Alcohol can further reduce blood sugar, risking hypoglycemia, and may heighten the risk of lactic acidosis.
Glidivas M 1mg/500mg Tabl...
56
MRP 68
17% off